Package Label-principal Display Panel (1.25 mg (100 Capsule Bottle))
Ramipril Capsule
Product Images NDC 57237-222
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 57237-222). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (2.5 mg (100 Capsule Bottle))
This text appears to be a table, without any context or additional information, it is not possible to provide a useful description.*
Package Label-principal Display Panel (5 mg (100 Capsule Bottle))
This is a description of the medication Ramipril, which is available in the form of hard gelatin capsules of 1.25mg strength in a package of 100 capsules. The instructions for dosage and administration are provided on the package insert. There is a warning to keep the medicine out of reach of children, and the pharmacist is advised to dispense it in a light-resistant, tight container with a child-resistant closure. The medicine should be stored at room temperature, between 20° and 25°C. The packaging was revised in 12/2017 by Rising Health, LLC, which is the distributor of the product. The drug has been manufactured in India and the packaging code is TS/DRUGS/19/1983.*
Package Label-principal Display Panel (10 mg (100 Capsule Bottle))
This is a description of Ramipril USP capsules manufactured by Rising Heath LLC in India. The container includes 100 hard gelatin capsules, with each capsule containing 2.5 mg of Ramipril. The dosage and administration instructions are included in the package, and caution is advised to keep it out of the reach of children. The pharmacist is advised to dispense the capsules in a container that is resistant to light and has a child-resistant closure. The capsules must be stored between 20°C to 25°C (68" 10 77°F), as per USP-controlled room temperature guidelines. *
Ramipril Fig5
Rising® wocsrz7-224-01 is a package of Ramipril Capsules, USP containing 100 capsules each. The hard gelatin capsule contains Ramipril USP & mg. Dosage and administration information should be read and package should be kept out of reach of children. Pharmacist should dispense in a light-resistant and tight container with a child-resistant closure. It should be stored at 20° to 25°C (68" 10 77°F) as per USP Controlled Room Temperature. It is distributed by Rising Heath, LLC and made in India. Lastly, the code TS/DRUGS/19/1983 was provided.*
Ramipril Fig6
Rising® nocsr2s7-225-01 is a USP approved medication that contains 10mg of Ramipril. It's provided in a package of 100 capsules, with dosage and administration instructions on the packaging. It has a warning to keep it out of reach of children, and pharmacies are advised to dispense it in a light-resistant, tight container with a child-resistant closure. It is recommended to store it at room temperature, between 20° to 25°C (68" 10 77°F). It is distributed by Rising Health, LLC, made in India, and the code TS/DRUGS/19/1983 is printed on the coding zone.*
Chemical Structure (Ramipril Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
